Insider Transactions in Q4 2024 at Good Rx Holdings, Inc. (GDRX)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 08
2024
|
Romin Nabiey Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,519
-5.2%
|
$22,595
$5.04 P/Share
|
|
Nov 08
2024
|
Romin Nabiey Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,663
+12.71%
|
-
|
|
Nov 08
2024
|
Scott Wagner Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
35,777
-12.33%
|
$178,885
$5.04 P/Share
|
|
Nov 08
2024
|
Scott Wagner Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
70,592
+19.57%
|
-
|
|
Nov 08
2024
|
Ronald E Bruehlman Director |
BUY
Grant, award, or other acquisition
|
Direct |
21,631
+49.33%
|
-
|
|
Oct 26
2024
|
Douglas Joseph Hirsch Director |
BUY
Grant, award, or other acquisition
|
Direct |
21,394
+6.42%
|
-
|
|
Oct 15
2024
|
Romin Nabiey Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
930
-1.24%
|
$5,580
$6.91 P/Share
|
|
Oct 15
2024
|
Romin Nabiey Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,606
+3.35%
|
-
|
|
Oct 08
2024
|
Scott Wagner Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
35,776
-14.02%
|
$250,432
$7.05 P/Share
|
|
Oct 08
2024
|
Scott Wagner Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
70,591
+21.66%
|
-
|